| abstract |
The invention provides a novel aryl-substituted methyl-connected bis-indoleacetic acid derivative represented by a general formula I, and a preparation method and application thereof. The aryl-substituted methyl-connected bis-indoleacetic acid derivative disclosed by the invention has the effect of inhibiting a tumor cell, has week toxic and side effects, and can be used as a clinical antitumor drug. |